| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 10.3MM | +3% |
| Gross Profit | 4.5MM | +11% |
| Cost Of Revenue | 5.8MM | -3% |
| Operating Income | -420K | -62% |
| Operating Expenses | 4.9MM | -4% |
| Net Income | -53.6K | -95% |
| G&A | 4.7MM | -6% |
| Amortization | 155.7K | - |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Research Solutions (NASDAQ: RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, today launches their new Clinical Trial Landscape software solution, making clinical trial information more accessible, insightful, and actionable. Clinical trials are essential research studies that assess the efficacy and safety of medical interventions, informing regulatory decisions, guiding healthcare practices, and advancing medical knowledge an
Key Insights Significantly high institutional ownership implies Research Solutions' stock price is sensitive to their...
Research Solutions (NASDAQ: RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, today launches their new Technology Landscape Module.
Long Cast Advisers, an investment management firm, released its fourth quarter 2023 investor letter, a copy of which can be downloaded here. While the major indices saw double-digit gains in certain situations, the cumulative returns of the fund for the 4Q23 quarter (which ended on December 31, 2023) were -8%. Cumulative net returns were +10% for the […]
Research Solutions, Inc. (NASDAQ:RSSS) Q2 2024 Earnings Call Transcript February 8, 2024 Research Solutions, Inc. beats earnings expectations. Reported EPS is $0.01, expectations were $-0.03. Research Solutions, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and welcome […]
Research Solutions, Inc. (NASDAQ: RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, reported financial results for its fiscal second quarter ended December 31, 2023.
Research Solutions, Inc. (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, will hold a conference call to discuss its financial results for the fiscal 2024 second quarter ended December 31, 2023, on Thursday, February 8, 2024, at 5:00 p.m. ET. A press release containing the company's financial results will be issued following the market close and prior to the call.
NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the 2024 Healthcare IT Virtual Conference. The conference will take place on Wednesday, January 24th, & Thursday, January 25th, 2024, starting at 9:00 a.m. ET. We will be presenting our 2024 Healthcare IT Virtual Conference. Allen Klee, Senior Research Analyst at Maxim Grou
Research Solutions, Inc. (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, today announced that Roy W. Olivier, President and CEO and Bill Nurthen, Chief Financial Officer will participate in the 2024 Healthcare IT Virtual Conference, presented by Maxim Group LLC, on Wednesday, January 24th at 3:30 pm ET.
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But investors can...